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STATE-OF-THE-ART PAPER STATE-OF-THE-ART PAPER635Pre-Diabetes, Metabolic Syndrome, and Cardiovascular RiskScott M. Grundy
Pre-diabetes is an elevation of plasma glucose above the normal range but below that of
clinical diabetes. Pre-diabetes commonly associates with the metabolic syndrome and both are
closely linked to obesity. Grundy reviews the literature and finds scant evidence that pre-
diabetes increases the risk of microvascular disease, but some evidence that the risk of
macrovascular complications is higher. Whether this increased risk is beyond that of the
metabolic syndrome is less clear. He concludes that the best approach to cardiovascular
prevention is to treat all of the metabolic risk factors with weight reduction and physical
activity and to treat elevations in cholesterol and blood pressure.VIEWPOINT VIEWPOINT644Post-MI Cardiogenic Shock Is a Systemic Illness in Need of Systemic TreatmentBrian M. Stegman, L. Kristin Newby, Judith S. Hochman, E. Magnus Ohman
Cardiogenic shock is the leading cause of death among hospitalized patients following
myocardial infarction (MI) with mortality rates of 50% despite rapid revascularization and
optimal medical care. Stegman and colleagues argue that new therapeutic strategies are
needed. Therapeutic hypothermia has multiple potentially beneficial physiologic effects,
including the potential to improve post-ischemic cardiac function and reduce end-organ injury
from prolonged hypoperfusion. Animal studies and uncontrolled human trials suggest that
systemic therapeutic hypothermia could decrease morbidity and mortality and warrants a trial
of its clinical efficacy and safety.(continued on page A-34)
FEBRUARY 14, 2012 (continued) A-34CLINICAL RESEARCHHINTERVENTIONAL CARDIOLOGY648Low Prevalence of PCI for ULMCA Stenosis in the United StatesJ. Matthew Brennan, David Dai, Manesh R. Patel, Sunil V. Rao, Ehrin J. Armstrong,
John C. Messenger, Jeptha P. Curtis, Kendrick A. Shunk, Kevin J. Anstrom, Eric L. Eisenstein,
William S. Weintraub, Eric D. Peterson, Pamela S. Douglas, William B. Hillegass
Percutaneous coronary intervention for unprotected left main coronary artery (ULMCA)
stenosis is controversial; the current use and outcomes of ULMCA PCI in U.S. clinical
practice has not been described. Brennan and colleagues evaluated 5,627 patients undergoing
ULMCA PCI at 693 centers within the NCDR CathPCI Registry from 2004 to 2008.
ULMCA PCI was performed in only 4.3% of patients found to have ULMCA stenosis.
Unadjusted in-hospital mortality rates ranged from 2.9% for elective cases to 45% for
emergent/salvage cases. By 30 months, 43% of the elderly ULMCA PCI population died. In
the United States, ULMCA PCI is performed in 5% of patients with ULMCA disease,
many of whom are suffering from catastrophic emergencies.CORONARY ARTERY DISEASE
655igh Prevalence of a Pathologic Response to ACH Infusion in
Patients With Stable Angina and Unobstructed Coronary ArteriesPeter Ong, Anastasios Athanasiadis, Gabor Borgulya, Heiko Mahrholdt, Juan Carlos Kaski, Udo Sechtem
Ong and colleagues speculated that abnormal coronary vasomotion may be causing
microvascular angina in patients with typical angina but no hemodynamically significant
stenoses. In 304 consecutive patients with exertional anginal symptoms undergoing diagnostic
angiography, one-half of the subjects had normal coronary arteries or only minimal
irregularities. These subjects underwent intracoronary acetylcholine (ACH) testing. Coronary
spasm was elicited in 62% of these subjects with an even distribution between epicardial
spasm and microvascular spasm. These results suggest that many patients with nonobstructive
coronary artery disease but typical symptoms of angina pectoris may be experiencing chest
pain related to abnormal coronary vasomotion.
Editorial Comment: Mario Marzilli, Alda Huqi, page 663(continued on page A-40)
FEBRUARY 14, 2012 (continued) A-40CORONARY ARTERY DISEASE665Relationships Between Fitness, Fatness, and Cardiovascular Risk FactorsDuck-chul Lee, Xuemei Sui, Timothy S. Church, Carl J. Lavie, Andrew S. Jackson, Steven N. Blair
Lee and colleagues examined the independent and combined associations of changes in fitness
and fatness with the subsequent development of hypertension, metabolic syndrome, and
hypercholesterolemia. Results were compiled from 3,148 healthy adults who received at least
3 medical examinations. Maintaining or improving fitness was associated with a lower risk of
developing each outcome, whereas increasing fatness was associated with a higher risk. In the
joint analyses, the increased risks associated with fat gain were attenuated, although not
completely eliminated, by maintaining or improving fitness. Similarly, the increased risks
associated with fitness loss were also somewhat attenuated when fatness was reduced. Both
fitness and fatness have important effects on mitigating the development of cardiovascular risk
factors.HEART FAILURE673LA Function Predicts Heart Failure Hospitalization in Subjects With Preserved EFChristine C. Welles, Ivy A. Ku, Damon M. Kwan, Mary A. Whooley, Nelson B. Schiller,
Mintu P. Turakhia
Welles and colleagues sought to determine if left atrial (LA) dysfunction predicts heart failure
(HF) hospitalization in subjects with preserved ejection fraction (EF). Left atrial functional
index (LAFI) was calculated in all subjects who were followed for 8 years. The rates of HF
hospitalization were inversely proportional to LAFI. This association persisted even after
adjustment for clinical risk factors, N-terminal-pro-B-type natriuretic peptide, and a wide
range of echocardiographic parameters. LA dysfunction independently predicts HF
hospitalization and may be useful for HF risk stratification and as a potential therapeutic
target.(continued on page A-42)
FEBRUARY 14, 2012 (continued) A-42HEART RHYTHM DISORDERS681Presentation of Patients With Lead-Associated EndocarditisArnold J. Greenspon, Jordan M. Prutkin, Muhammad R. Sohail, Holenarasipur R. Vikram,
Larry M. Baddour, Stephan B. Danik, James Peacock, Carlos Falces, Jose M. Miro, Elisabeth Blank,
Christoph Naber, Roger G. Carrillo, Chi-Hong Tseng, Daniel Z. Uslan
Greenspon and colleagues sought to determine whether the timing of the most recent cardiac
implantable electronic device (CIED) procedure influences the clinical presentation and
outcome of lead-associated endocarditis (LAE). Consecutive LAE patients enrolled in
registry of LAE cases were reviewed. Early (6 months after implantation) LAE patients
presented with signs and symptoms of local pocket infection, but late presenters rarely had
pocket involvement. A remote source of bacteremia was present in 38% of patients with late
but only 8% of early LAE. These findings offer diagnostic clues for identifying LAE in
patients with a CIED.CARDIAC IMAGING688Weak Correlation Between CCTA Findings and Stress Test ResultsKavitha M. Chinnaiyan, Gilbert L. Raff, Tauqir Goraya, Karthikeyan Ananthasubramaniam,
Michael J. Gallagher, Aiden Abidov, Judith A. Boura, David Share, Patricia A. Peyser
Chinnaiyan and colleagues evaluated the correlation between stress test results and coronary
computed tomography angiography (CCTA) findings and the comparative diagnostic
performance of the 2 modalities. Results were compiled from almost 7,000 patients without
known coronary artery disease who had a CCTA and a stress test; a subset underwent
invasive coronary angiography (ICA). Stress test results were not predictive of finding a
50% stenosis on CCTA. Among patients undergoing ICA, there was a strong correlation
between ICA and CCTA findings, but not stress test results. These findings question the
accuracy of stress testing for predicting a 50% stenosis and suggest that CCTA may serve
as an effective “gatekeeper” to invasive testing in patients with abnormal stress test results.Editorial Comment: Pim J. de Feyter, Koen Nieman, page 696
